Oric Pharmaceuticals, Inc. - ORIC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | VIKING GLOBAL INVESTORS LP | 7.8% | 8,264,607 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Parent GP LLC | 7.8% | 8,264,607 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities GP LLC | 5.0% | 5,250,103 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Portfolio GP LLC | 5.0% | 5,250,103 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Illiquid Investments Sub-Master LP | 5.0% | 5,250,103 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown GP LLC | 2.8% | 3,014,504 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown Portfolio GP LLC | 2.8% | 3,014,504 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown (Aggregator) LP | 2.8% | 3,014,504 | View |
| May 15, 2026 | SCHEDULE 13G/A | HALVORSEN OLE ANDREAS | 7.8% | 8,264,607 | View |
| May 15, 2026 | SCHEDULE 13G/A | Shabet Rose Sharon | 7.8% | 8,264,607 | View |
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 4.2% | 4,319,765 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 4.2% | 4,319,765 | View |
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 4.2% | 4,319,765 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 4.2% | 4,319,765 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 4.2% | 4,319,765 | View |
| May 15, 2026 | SCHEDULE 13G/A | Nimish Shah | 4.2% | 4,319,765 | View |
| May 15, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 4.2% | 4,319,765 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G | T. Rowe Price Associates, Inc. | 5.4% | 5,387,783 | View |
| May 12, 2026 | SCHEDULE 13G/A | Pfizer Inc. (IRS Identification No.: 13-5315170) | 3.3% | 3,442,940 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Nimish Shah | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 5.8% | 5,676,230 | View |
| Jan 21, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.6% | 5,473,145 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.